Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition
Alessio Vittorio Colombo, Rebecca Katie Sadler, Gemma Llovera, Vikramjeet Singh, Stefan Roth, Steffanie Heindl, Laura Sebastian Monasor, Aswin Verhoeven, Finn Peters, Samira Parhizkar, Frits Kamp, Mercedes Gomez de Aguero, Andrew J MacPherson, Edith Winkler, Jochen Herms, Corinne Benakis, Martin Dichgans, Harald Steiner, Martin Giera, Christian Haass, Sabina Tahirovic, Arthur Liesz, Alessio Vittorio Colombo, Rebecca Katie Sadler, Gemma Llovera, Vikramjeet Singh, Stefan Roth, Steffanie Heindl, Laura Sebastian Monasor, Aswin Verhoeven, Finn Peters, Samira Parhizkar, Frits Kamp, Mercedes Gomez de Aguero, Andrew J MacPherson, Edith Winkler, Jochen Herms, Corinne Benakis, Martin Dichgans, Harald Steiner, Martin Giera, Christian Haass, Sabina Tahirovic, Arthur Liesz
Abstract
Previous studies have identified a crucial role of the gut microbiome in modifying Alzheimer's disease (AD) progression. However, the mechanisms of microbiome-brain interaction in AD were so far unknown. Here, we identify microbiota-derived short chain fatty acids (SCFA) as microbial metabolites which promote Aβ deposition. Germ-free (GF) AD mice exhibit a substantially reduced Aβ plaque load and markedly reduced SCFA plasma concentrations; conversely, SCFA supplementation to GF AD mice increased the Aβ plaque load to levels of conventionally colonized (specific pathogen-free [SPF]) animals and SCFA supplementation to SPF mice even further exacerbated plaque load. This was accompanied by the pronounced alterations in microglial transcriptomic profile, including upregulation of ApoE. Despite increased microglial recruitment to Aβ plaques upon SCFA supplementation, microglia contained less intracellular Aβ. Taken together, our results demonstrate that microbiota-derived SCFA are critical mediators along the gut-brain axis which promote Aβ deposition likely via modulation of the microglial phenotype.
Keywords: alzheimer's disease; amyloid; immunology; inflammation; metabolites; microbiome; microglia; mouse; neuroinflammation; neuroscience.
Conflict of interest statement
AC, RS, GL, VS, SR, SH, LS, AV, FP, SP, FK, MG, EW, JH, CB, MD, HS, MG, CH, ST, AL No competing interests declared, AM Reviewing editor, eLife
© 2021, Colombo et al.
Figures
References
- Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK. Microbiome–microglia connections via the gut–brain axis. Journal of Experimental Medicine. 2019;216:41–59. doi: 10.1084/jem.20180794.
- Attar A, Liu T, Chan WT, Hayes J, Nejad M, Lei K, Bitan G. A shortened barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease. PLOS ONE. 2013;8:e80355. doi: 10.1371/journal.pone.0080355.
- Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut Microbiota as an environmental factor that regulates fat storage. PNAS. 2004;101:15718–15723. doi: 10.1073/pnas.0407076101.
- Benakis C, Martin-Gallausiaux C, Trezzi JP, Melton P, Liesz A, Wilmes P. The microbiome-gut-brain Axis in acute and chronic brain diseases. Current Opinion in Neurobiology. 2020;61:1–9. doi: 10.1016/j.conb.2019.11.009.
- Bohlen CJ, Bennett FC, Tucker AF, Collins HY, Mulinyawe SB, Barres BA. Diverse requirements for microglial survival, specification, and function revealed by Defined-Medium cultures. Neuron. 2017;94:759–773. doi: 10.1016/j.neuron.2017.04.043.
- Brandscheid C, Schuck F, Reinhardt S, Schäfer KH, Pietrzik CU, Grimm M, Hartmann T, Schwiertz A, Endres K. Altered gut microbiome composition and tryptic activity of the 5xfad alzheimer's Mouse Model. Journal of Alzheimer's Disease. 2017;56:775–788. doi: 10.3233/JAD-160926.
- Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nature Neuroscience. 2014;17:131–143. doi: 10.1038/nn.3599.
- Colombo A, Dinkel L, Müller SA, Sebastian Monasor L, Schifferer M, Cantuti-Castelvetri L, König J, Vidatic L, Bremova-Ertl T, Lieberman AP, Hecimovic S, Simons M, Lichtenthaler SF, Strupp M, Schneider SA, Tahirovic S. Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia. Nature Communications. 2021;12:1158. doi: 10.1038/s41467-021-21428-5.
- Cramer JV, Benakis C, Liesz A. T cells in the post-ischemic brain: troopers or paramedics? Journal of Neuroimmunology. 2019;326:33–37. doi: 10.1016/j.jneuroim.2018.11.006.
- Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E, O'Connor R, Cruz-Pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-Silva AP, Wallace-Fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain axis. Physiological Reviews. 2019;99:1877–2013. doi: 10.1152/physrev.00018.2018.
- Cryan JF, O'Mahony SM. The microbiome-gut-brain Axis: from bowel to behavior. Neurogastroenterology & Motility. 2011;23:187–192. doi: 10.1111/j.1365-2982.2010.01664.x.
- Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nature Reviews Gastroenterology & Hepatology. 2019;16:461–478. doi: 10.1038/s41575-019-0157-3.
- Daria A, Colombo A, Llovera G, Hampel H, Willem M, Liesz A, Haass C, Tahirovic S. Young microglia restore amyloid plaque clearance of aged microglia. The EMBO Journal. 2017;36:583–603. doi: 10.15252/embj.201694591.
- Davie JR. Inhibition of histone deacetylase activity by butyrate. The Journal of Nutrition. 2003;133:2485S–2493. doi: 10.1093/jn/133.7.2485S.
- Dodiya HB, Kuntz T, Shaik SM, Baufeld C, Leibowitz J, Zhang X, Gottel N, Zhang X, Butovsky O, Gilbert JA, Sisodia SS. Sex-specific effects of microbiome perturbations on cerebral aβ amyloidosis and microglia phenotypes. Journal of Experimental Medicine. 2019;216:1542–1560. doi: 10.1084/jem.20182386.
- Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermöhlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M. Host Microbiota constantly control maturation and function of microglia in the CNS. Nature Neuroscience. 2015;18:965–977. doi: 10.1038/nn.4030.
- Guillot-Sestier MV, Doty KR, Town T. Innate immunity fights Alzheimer's Disease. Trends in Neurosciences. 2015;38:674–681. doi: 10.1016/j.tins.2015.08.008.
- Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N, Balogh A, Ostermann AI, Schebb NH, Akkad DA, Grohme DA, Kleinewietfeld M, Kempa S, Thöne J, Demir S, Müller DN, Gold R, Linker RA. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity. 2015;43:817–829. doi: 10.1016/j.immuni.2015.09.007.
- Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s disease. Journal of Cell Biology. 2018;217:459–472. doi: 10.1083/jcb.201709069.
- Harach T, Marungruang N, Duthilleul N, Cheatham V, Mc Coy KD, Frisoni G, Neher JJ, Fåk F, Jucker M, Lasser T, Bolmont T. Reduction of abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut Microbiota. Scientific Reports. 2017;7:41802. doi: 10.1038/srep41802.
- Haran JP, Bhattarai SK, Foley SE, Dutta P, Ward DV, Bucci V, McCormick BA. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway. mBio. 2019;10:e00632-19. doi: 10.1128/mBio.00632-19.
- Hefendehl JK, Wegenast-Braun BM, Liebig C, Eicke D, Milford D, Calhoun ME, Kohsaka S, Eichner M, Jucker M. Long-term in vivo imaging of β-amyloid plaque appearance and growth in a mouse model of cerebral β-amyloidosis. Journal of Neuroscience. 2011;31:624–629. doi: 10.1523/JNEUROSCI.5147-10.2011.
- Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 2013;493:674–678. doi: 10.1038/nature11729.
- Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nature Reviews Immunology. 2014;14:463–477. doi: 10.1038/nri3705.
- Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM. Protective roles of intestinal Microbiota derived short chain fatty acids in Alzheimer's disease-type beta-amyloid neuropathological mechanisms. Expert Review of Neurotherapeutics. 2018;18:83–90. doi: 10.1080/14737175.2018.1400909.
- Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in alzheimer disease. Cold Spring Harbor Perspectives in Medicine. 2012;2:a006312. doi: 10.1101/cshperspect.a006312.
- Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, Lemere CA, Selkoe DJ, Stevens B. Complement and microglia mediate early synapse loss in alzheimer mouse models. Science. 2016;352:712–716. doi: 10.1126/science.aad8373.
- Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291:881–884. doi: 10.1126/science.291.5505.881.
- Hoving LR, Heijink M, van Harmelen V, van Dijk KW, Giera M. GC-MS analysis of Short-Chain fatty acids in feces, cecum content, and blood samples. Methods in Molecular Biology. 2018;1730:247–256. doi: 10.1007/978-1-4939-7592-1_17.
- Huuskonen J, Suuronen T, Nuutinen T, Kyrylenko S, Salminen A. Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids. British Journal of Pharmacology. 2004;141:874–880. doi: 10.1038/sj.bjp.0705682.
- Janakiraman M, Krishnamoorthy G. Emerging role of diet and Microbiota interactions in neuroinflammation. Frontiers in Immunology. 2018;9:2067. doi: 10.3389/fimmu.2018.02067.
- Layden BT, Angueira AR, Brodsky M, Durai V, Lowe WL. Short chain fatty acids and their receptors: new metabolic targets. Translational Research. 2013;161:131–140. doi: 10.1016/j.trsl.2012.10.007.
- Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C. Emerging microglia biology defines novel therapeutic approaches for alzheimer's Disease. Neuron. 2020;108:801–821. doi: 10.1016/j.neuron.2020.09.029.
- Li Z, Yi CX, Katiraei S, Kooijman S, Zhou E, Chung CK, Gao Y, van den Heuvel JK, Meijer OC, Berbée JFP, Heijink M, Giera M, Willems van Dijk K, Groen AK, Rensen PCN, Wang Y. Butyrate reduces appetite and activates Brown adipose tissue via the gut-brain neural circuit. Gut. 2018;67:1269–1279. doi: 10.1136/gutjnl-2017-314050.
- Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, Sullivan PM, Holtzman DM. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Acta Neuropathologica Communications. 2015;3:70. doi: 10.1186/s40478-015-0250-y.
- Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine. 2009;15:192–199. doi: 10.1038/nm.1927.
- Lin HV, Frassetto A, Kowalik EJ, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLOS ONE. 2012;7:e35240. doi: 10.1371/journal.pone.0035240.
- Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312–339. doi: 10.1016/j.cell.2019.09.001.
- Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, Mombelli E, Mazzelli M, Luongo D, Naviglio D, Coppola L, Salvatore M, Frisoni GB. Short-Chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer's Disease. Journal of Alzheimer's Disease. 2020;78:683–697. doi: 10.3233/JAD-200306.
- Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Research. 2015;43:W566–W570. doi: 10.1093/nar/gkv468.
- Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, Musch MW, Liao F, Ward JF, Holtzman DM, Chang EB, Tanzi RE, Sisodia SS. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of alzheimer's disease. Scientific Reports. 2016;6:30028. doi: 10.1038/srep30028.
- Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, Oyler-Castrillo P, Zhang X, Musch MW, Shen X, Jabri B, Chang EB, Tanzi RE, Sisodia SS. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer's disease. Scientific Reports. 2017;7:10411. doi: 10.1038/s41598-017-11047-w.
- Morrison DJ, Preston T. Formation of short chain fatty acids by the gut Microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189–200. doi: 10.1080/19490976.2015.1134082.
- Moschen I, Bröer A, Galić S, Lang F, Bröer S. Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT) Neurochemical Research. 2012;37:2562–2568. doi: 10.1007/s11064-012-0857-3.
- Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine. 2019;47:529–542. doi: 10.1016/j.ebiom.2019.08.032.
- Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, Tahirovic S, Herms J, Willem M, Pettkus N, Butovsky O, Bartenstein P, Edbauer D, Rominger A, Ertürk A, Grathwohl SA, Neher JJ, Holtzman DM, Meyer-Luehmann M, Haass C. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nature Neuroscience. 2019;22:191–204. doi: 10.1038/s41593-018-0296-9.
- Peters F, Salihoglu H, Rodrigues E, Herzog E, Blume T, Filser S, Dorostkar M, Shimshek DR, Brose N, Neumann U, Herms J. BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology. Acta Neuropathologica. 2018;135:695–710. doi: 10.1007/s00401-017-1804-9.
- Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jäggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, Hölscher C, Mathews PM, Jucker M. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Reports. 2006;7:940–946. doi: 10.1038/sj.embor.7400784.
- Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human Microbiota. Science. 2011;332:974–977. doi: 10.1126/science.1206095.
- Sadler R, Singh V, Benakis C, Garzetti D, Brea D, Stecher B, Anrather J, Liesz A. Microbiota differences between commercial breeders impacts the post-stroke immune response. Brain, Behavior, and Immunity. 2017;66:23–30. doi: 10.1016/j.bbi.2017.03.011.
- Sadler R, Cramer JV, Heindl S, Kostidis S, Betz D, Zuurbier KR, Northoff BH, Heijink M, Goldberg MP, Plautz EJ, Roth S, Malik R, Dichgans M, Holdt LM, Benakis C, Giera M, Stowe AM, Liesz A. Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms. The Journal of Neuroscience. 2020;40:1162–1173. doi: 10.1523/JNEUROSCI.1359-19.2019.
- Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, Mancuso R, Chen WT, Woodbury ME, Srivastava G, Möller T, Hudry E, Das S, Saido T, Karran E, Hyman B, Perry VH, Fiers M, De Strooper B. The major risk factors for alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques. Cell Reports. 2019;27:1293–1306. doi: 10.1016/j.celrep.2019.03.099.
- Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK. Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's Disease. Cell. 2016;167:1469–1480. doi: 10.1016/j.cell.2016.11.018.
- Sarlus H, Heneka MT. Microglia in Alzheimer’s disease. Journal of Clinical Investigation. 2017;127:3240–3249. doi: 10.1172/JCI90606.
- Sebastian Monasor L, Müller SA, Colombo AV, Tanrioever G, König J, Roth S, Liesz A, Berghofer A, Piechotta A, Prestel M, Saito T, Saido TC, Herms J, Willem M, Haass C, Lichtenthaler SF, Tahirovic S. Fibrillar aβ triggers microglial proteome alterations and dysfunction in alzheimer mouse models. eLife. 2020;9:e54083. doi: 10.7554/eLife.54083.
- Shi Y, Holtzman DM. Interplay between innate immunity and alzheimer disease: apoe and TREM2 in the spotlight. Nature Reviews Immunology. 2018;18:759–772. doi: 10.1038/s41577-018-0051-1.
- Shirotani K, Tomioka M, Kremmer E, Haass C, Steiner H. Pathological activity of familial alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes. Neurobiology of Disease. 2007;27:102–107. doi: 10.1016/j.nbd.2007.04.011.
- Singh V, Roth S, Llovera G, Sadler R, Garzetti D, Stecher B, Dichgans M, Liesz A. Microbiota dysbiosis controls the neuroinflammatory response after stroke. Journal of Neuroscience. 2016;36:7428–7440. doi: 10.1523/JNEUROSCI.1114-16.2016.
- Singh V, Sadler R, Heindl S, Llovera G, Roth S, Benakis C, Liesz A. The gut microbiome primes a cerebroprotective immune response after stroke. Journal of Cerebral Blood Flow & Metabolism. 2018;38:1293–1298. doi: 10.1177/0271678X18780130.
- Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science. 2013;341:569–573. doi: 10.1126/science.1241165.
- Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, Zhang Y, Spevak W, Lin J, Phan NY, Habets G, Rymar A, Tsang G, Walters J, Nespi M, Singh P, Broome S, Ibrahim P, Zhang C, Bollag G, West BL, Green KN. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model. Nature Communications. 2019;10:3758. doi: 10.1038/s41467-019-11674-z.
- Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: a review. Annals of Neurology. 2017;81:369–382. doi: 10.1002/ana.24901.
- van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O'Sullivan O, Clarke G, Stanton C, Dinan TG, Cryan JF. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut Axis alterations. The Journal of Physiology. 2018;596:4923–4944. doi: 10.1113/JP276431.
- Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, Griep A, Gelpi E, Beilharz M, Riedel D, Golenbock DT, Geyer M, Walter J, Latz E, Heneka MT. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease. Nature. 2017;552:355–361. doi: 10.1038/nature25158.
- Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K, Bendlin BB, Rey FE. Gut microbiome alterations in Alzheimer's disease. Scientific Reports. 2017;7:13537. doi: 10.1038/s41598-017-13601-y.
- Winkler E, Kamp F, Scheuring J, Ebke A, Fukumori A, Steiner H. Generation of alzheimer Disease-associated amyloid β42/43 peptide by γ-Secretase can be inhibited directly by modulation of membrane thickness. Journal of Biological Chemistry. 2012;287:21326–21334. doi: 10.1074/jbc.M112.356659.
- Yamasaki A, Eimer S, Okochi M, Smialowska A, Kaether C, Baumeister R, Haass C, Steiner H. The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase. Journal of Neuroscience. 2006;26:3821–3828. doi: 10.1523/JNEUROSCI.5354-05.2006.
Source: PubMed